Keisha L. Gibson, MD, MPH, is a physician scientist and the division chief of Pediatric Nephrology department at UNC School ...

Investigators evaluated outcomes after endoscopic kidney-sparing surgery for upper tract urothelial carcinoma (UTUC).

Degevma (denosumab-adet) has received FDA approval as a biosimilar to Xgeva, demonstrating bioequivalence in safety, efficacy, and immunogenicity. The Food and Drug Administration (FDA) has approved ...

A bladder-sparing active surveillance program reported on outcomes in patients with muscle-invasive bladder cancer (MIBC).

GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.

Researchers found an association between increased risk for incidence and progression of diabetic nephropathy in patients with type 2 diabetes.

Researchers found that use of certain catheter-associated urinary tract infection prevention practices has improved over time in the US.

An observational study suggests benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in end-stage kidney ...

Hydralazine daily doses greater than 200 mg can be associated with severe overlapping autoimmune syndromes, including lupus erythematosus and ANCA-associated vasculitis. A 71-year-old man presented ...

Although cannabis and CBD can offer modest symptom relief for chronic pain, health care providers should counsel patients on outcomes and drug interactions before use. For health care providers who ...

A study showed that certain pregnancy complications are associated with an increased risk for cardiometabolic-renal conditions in subsequent years.

A meta-analysis of randomized trials supports intensive blood pressure lowering in chronic kidney disease (CKD) not on dialysis.